Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sears Capital Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 5
Rounds per year 0.31
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 3
Key employees 1
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Medical
  • Health Diagnostics
  • Health Care
Summary

Sears Capital Management is the famous VC, which was founded in 1994. The main department of described VC is located in the Cupertino. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Sears Capital Management, startups are often financed by Asset Management Company, BioBrit, Vivo Capital. The meaningful sponsors for the fund in investment in the same round are BioBrit, Vivo Capital, Sofinnova Investments. In the next rounds fund is usually obtained by Asset Management Company, VentureSouth, OrbiMed.

Besides them, we counted 1 critical employee of this fund in our database.

Opposing the other organizations, this Sears Capital Management works on 0 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2013. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Medical, Biopharma. Among the various public portfolio startups of the fund, we may underline CharlestonPharma,LLC, SiteOne Therapeutics, Peninsula Pharmaceuticals The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sears Capital Management:
Typical Co-investors
Sears Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sears Capital Management:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Academy Venture Fund -
Breakpoint Ventures Chicago, Illinois, United States
Build Capital Group -
Cardinal Capital Central Region, Singapore, Singapore
GaiaX Makati, Manila, Philippines
Greenstone Equity Partners Dubai, United Arab Emirates
Hebo Investments -
Ignition Group Italy, Lombardia, Milano
JS Corp Seoul, Seoul-t'ukpyolsi, South Korea
Kalei Ventures -
Keppel Communications -
Mix Labs -
Oracle Strategic Partners Connecticut, Greenwich, United States
QC Capital China, Guangdong, Shenzhen
Quaker Partners Pennsylvania, Philadelphia, United States
StarVest Partners New York, New York, United States
Tactics II Investments -
Thiel Capital California, Los Angeles, United States
Yuliang Electronic Commerce China, Yiwu, Zhejiang
Zhencheng Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$15M06 Jan 2017 Bozeman, Montana, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$1M24 Sep 2014 Bozeman, Montana, United States

InteKrin

Biotechnology
Neuroscience
Therapeutics
$18M04 Aug 2008 California, United States

InteKrin

Biotechnology
Neuroscience
Therapeutics
$23M12 Jan 2007 California, United States

Peninsula Pharmaceuticals

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
$22M28 Oct 2002 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sears Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 13M
Rounds per year 0.31
Peak activity year 2008
Lead investments 1
Follow on index 0.33
Exits 3
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$15M06 Jan 2017 Bozeman, Montana, United States

SiteOne Therapeutics

Biotechnology
Health Diagnostics
Medical
Therapeutics
$1M24 Sep 2014 Bozeman, Montana, United States

InteKrin

Biotechnology
Neuroscience
Therapeutics
$18M04 Aug 2008 California, United States

InteKrin

Biotechnology
Neuroscience
Therapeutics
$23M12 Jan 2007 California, United States

Peninsula Pharmaceuticals

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
$22M28 Oct 2002 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: